Hubbry Logo
search button
Sign in
Elsilimomab
Elsilimomab
Comunity Hub
History
arrow-down
starMore
arrow-down
bob

Bob

Have a question related to this hub?

bob

Alice

Got something to say related to this hub?
Share it here.

#general is a chat channel to discuss anything related to the hub.
Hubbry Logo
search button
Sign in
Elsilimomab
Community hub for the Wikipedia article
logoWikipedian hub
Welcome to the community hub built on top of the Elsilimomab Wikipedia article. Here, you can discuss, collect, and organize anything related to Elsilimomab. The purpose of the hub is to connect people, f...
Add your contribution
Elsilimomab
Elsilimomab
Monoclonal antibody
TypeWhole antibody
SourceMouse
TargetIL-6
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
 ☒NcheckY (what is this?)  (verify)

Elsilimomab (also known as B-E8) is a mouse monoclonal antibody.[1] B-E8 was developed by Diaclone,[2] a French company which produces many mouse monoclonal antibodies.

It (OPR-003) targets (and blocks) Interleukin-6.[3]

It has undergone a number of early stage clinical trials, e.g. for lymphoma and myeloma.[4]

It was used as a template to develop a high-affinity, antagonist, fully human anti-IL-6 mAb 1339.[4]

References

[edit]
  1. ^ "WHO Drug Information" (PDF). Archived from the original (PDF) on October 16, 2009. p11:immunoglobulin G1, anti-(human interleukin 6) (mouse monoclonal B-E8 heavy chain), disulfide with mouse monoclonal B-E8 k-chain, dimer
  2. ^ "Datasheet B-E8 mAb". Diaclone.
  3. ^ "First Fully Human Anti-IL6 Antibody Under Development". Genetic Engineering & Biotechnology News. Oct 2006.
  4. ^ a b Fulciniti M, Hideshima T, Vermot-Desroches C, Pozzi S, Nanjappa P, Shen Z, et al. (December 2009). "A high-affinity fully human anti-IL-6 mAb, 1339, for the treatment of multiple myeloma". Clinical Cancer Research. 15 (23): 7144–52. doi:10.1158/1078-0432.CCR-09-1483. PMC 2787636. PMID 19934301.